Fast-acting Human Insulin Market

Global Fast-acting Human Insulin Market Size, Trends & Analysis - Forecasts to 2028 By Product Type (Lispro Insulin, Aspart Insulin, and Glulisine Insulin), By Diabetes Type (Type 1 Diabetes and Type 2 Diabetes), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

Category Healthcare

Format

This report was recently updated on April 22 2024 with the latest and most recent market numbers

Global Fast-acting Human Insulin Market Size

The global fast-acting human insulin market is expected to grow at a CAGR of 4.5% from 2023 to 2028. Fast-acting human insulin is designed to work quickly after injection and generally start working in under 15 minutes and peak in an hour or two. People with diabetes frequently use fast-acting insulin to manage blood sugar levels during meals.

The main driving factors of the fast-acting insulin market are the rise in the prevalence of diabetic patients and the growth in the healthcare infrastructure for diabetes. The increasing global prevalence of diabetes for both type 1 and type 2 is driving the growth of the global fast-acting insulin market. Type 2 makes for up to 90% of all diabetes cases. Based on the increase in diabetic patients, there is an increase in insulin demand, especially for the fast-acting variations of the same. Developing healthcare infrastructure in emerging markets has made insulin accessible to the masses. The technological advancements in insulin delivery systems, such as insulin pumps and pens, have improved the ease and accuracy of insulin administration.

The market has its own set of restraints. The introduction of biosimilar products in the market negatively impact the market for fast-acting insulin. They are cheaper and are a popular source of alternatives. There are also regulatory hurdles in terms of the trials that are conducted based on the success rates and approvals, which can delay the commercialization of new formulations of fast-acting insulin.

global fast-acting human insulin market

Global Fast-acting Human Insulin Market: By Product Type

Based on product type, the market is segmented into lispro insulin, aspart insulin, and glulisine insulin. Lispro insulin segment is expected to be the dominant segment during the forecast period. The growth is attributed to the fact that it is prescribed for both type 1 (above the age of 3) and type 2 diabetics.

Aspart insulin segment is anticipated to exhibit highest CAGR during the forecast period from 2023 to 2028. Type 2 diabetic patients mainly use this prescription insulin. The percentage of type 2 diabetic patients is higher than type 1 diabetic patients. This factor drives the demand for aspart insulin.

Global Fast-acting Human Insulin Market: By Diabetes Type

Based on diabetes type, the market is segmented into type 1 diabetes and type 2 diabetes. Type 2 segment is expected to hold the largest share of the market over the forecast period. This is because type 2 is more prevalent than type 1 diabetes. It is preventable or can be brought under control with changes in lifestyle.

Type 1 is expected to be the fastest growing segment of diabetes during the forecast period. It is common amongst children. Type 1 is considered to be an auto-immune disorder where the body mistakenly destroys cells responsible for insulin production in the pancreas and its preventive measures are yet to be confirmed. The increasing research and development activities to come up with more ways to prevent the occurrence of type 1 diabetes amongst children is driving the growth of the segment.

Global Fast-acting Human Insulin Market: By Distribution Channel

Based on distribution channel, the market is segmented into hospital pharmacies, drug stores & retail pharmacies, online providers. Drug stores and retail pharmacies segment is expected to hold the largest share of the market in the forecast period because they are located everywhere. They are also a one stop shop for alternatives of the prescribed medication in case of unavailability.

Online stores segment is expected to witness fastest growth during the forecast period from 2023 to 2028, owing to the penetration of e-commerce across all sectors and the possibility of availing medication of physically inaccessible stores due to their distance, which supply the medication in case the pharmacy shops are out of stock.

asia pacific fast-acting human insulin market

Global Fast-acting Human Insulin Market: By Region

North America is analyzed to be the largest region in the global fast-acting human insulin market during the forecast period. The presence of the major pharma companies in North America involved in the production and marketing of insulin products. The region is also known for the research and development for insulin formulations. There is also a steady rise in type 2 diabetes amongst adults and children.

Asia Pacific is anticipated to be the fastest growing region across the global fast-acting human insulin market. Asia is known to have a high percentage of diabetic patients up to 60% population with Pakistan and China having the highest count for type 2. The increase in the occurrence of type 2 can be attributed to rapid urbanization and sedentary lifestyle. To tackle the risk, there is significant investments in the research and development for preventive drugs and newer formulations.

Global Fast-acting Human Insulin Market Share and Competitor Analysis

The key players operating in the market are Sanofi S.A., Geropharm LLC, Gan & Lee Pharmaceuticals, Wockhardt Ltd., Novo Nordisk A/S, Eli Lilly and Company, Mannkind Corporation, Biocon Limited, ADOCIA SAS, and Julphar, among others.

Please note: This is not an exhaustive list of companies profiled in the report.

Recent Developments

In November 2022, Biocon successfully aquired Viatris’ Global Biosimilars Business, which will give Biocon access to direct commercial capabilities and supporting infrastructure

1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS

1.1 Strategic Opportunity & Attractiveness Analysis

1.1.1 Hot Revenue Pockets

1.1.2 Market Attractiveness Score

1.1.3 Revenue Impacting Opportunity

1.1.4 High Growing Region/Country

1.1.5 Competitor Analysis

1.1.6 Consumer Analysis

1.2 Global Market Estimates' View

1.3 Strategic Insights across Business Functions

1.3.1 For Chief Executive Officers

1.3.2 For Chief Marketing Officers

1.3.3 For Chief Strategy Officers

1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into

2 TECHNOLOGICAL TRENDS

2.1 Technological Adoption Rate

2.2 Current Trend Impact Analysis

2.3 Future Trend Impact Analysis

3 GLOBAL FAST-ACTING HUMAN INSULIN MARKET OUTLOOK

3.1 Market Pyramid Analysis

3.1.1 Introduction

3.1.2 Adjacent Market Opportunities

3.1.3 Ancillary Market Opportunities

3.2 Demand Side Analysis

3.2.1 Market Drivers: Impact Analysis

3.2.2 Market Restraints: Impact Analysis

3.2.3 Market Opportunities: Impact Analysis

3.2.4 Market Challenges: Impact Analysis

3.3 Supply Side Analysis

3.3.1 Porter’s Five Forces Analysis

3.3.1.1 Threat of New Entrants

3.3.1.2 Threat of New Substitutes

3.3.1.3 Bargaining Power of Suppliers

3.3.1.4 Bargaining Power of Buyers

3.3.1.5 Intensity of Competitive Rivalry

3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)

3.3.2.1 Political Landscape

3.3.2.2 Economic Landscape

3.3.2.3 Social Landscape

3.3.2.4 Technology Landscape

3.3.3 Value Chain Analysis

3.3.4 Trend Analysis

3.3.5 Gap Analysis

3.3.6 Cost Analysis

4 GLOBAL FAST-ACTING HUMAN INSULIN MARKET, BY PRODUCT TYPE

4.1 Introduction

4.2 Fast-acting Human Insulin Market: Product Type Scope Key Takeaways

4.3 Revenue Growth Analysis, 2022 & 2028

4.4 Lispro Insulin

4.4.1 Lispro Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

4.5 Aspart Insulin

4.5.1 Aspart Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

4.6 Glulisine Insulin

4.6.1 Glulisine Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

5 GLOBAL FAST-ACTING HUMAN INSULIN MARKET, BY DIABETES TYPE

5.1 Introduction

5.2 Fast-acting Human Insulin Market: Diabetes Type Scope Key Takeaways

5.3 Revenue Growth Analysis, 2022 & 2028

5.4 Type 1 Diabetes

5.4.1 Type 1 Diabetes Market Estimates and Forecast, 2020-2028 (USD Million)

5.5 Type 2 Diabetes

5.5.1 Type 2 Diabetes Market Estimates and Forecast, 2020-2028 (USD Million)

6 GLOBAL FAST-ACTING HUMAN INSULIN MARKET, BY DISTRIBUTION CHAN NEL

6.1 Introduction

6.2 Fast-acting Human Insulin Market: Distribution Channel Scope Key Takeaways

6.3 Revenue Growth Analysis, 2022 & 2028

6.4 Hospital Pharmacies

6.4.1 Hospital Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

6.5 Drug Stores & Retail Pharmacies

6.5.1 Drug Stores & Retail Pharmacies Market Estimates and Forecast, 2020-2028 (USD Million)

6.6 Online Providers

6.6.1 Online Providers Market Estimates and Forecast, 2020-2028 (USD Million)

7 GLOBAL FAST-ACTING HUMAN INSULIN MARKET, BY REGION

7.1 Introduction

7.2 North America Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.1 By Product Type

7.2.2 By Diabetes Type

7.2.3 By Distribution Channel

7.2.4 By Country

7.2.4.1 U.S. Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.1.1 By Product Type

7.2.4.1.2 By Diabetes Type

7.2.4.1.3 By Distribution Channel

7.2.4.2 Canada Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.2.1 By Product Type

7.2.4.2.2 By Diabetes Type

7.2.4.2.3 By Distribution Channel

7.2.4.3 Mexico Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.3.1 By Product Type

7.2.4.3.2 By Diabetes Type

7.2.4.3.3 By Distribution Channel

7.3 Europe Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.1 By Product Type

7.3.2 By Diabetes Type

7.3.3 By Distribution Channel

7.3.4 By Country

7.3.4.1 Germany Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.1.1 By Product Type

7.3.4.1.2 By Diabetes Type

7.3.4.1.3 By Distribution Channel

7.3.4.2 U.K. Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.2.1 By Product Type

7.3.4.2.2 By Diabetes Type

7.3.4.2.3 By Distribution Channel

7.3.4.3 France Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.3.1 By Product Type

7.3.4.3.2 By Diabetes Type

7.3.4.3.3 By Distribution Channel

7.3.4.4 Italy Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.4.1 By Product Type

7.3.4.4.2 By Diabetes Type

7.2.4.4.3 By Distribution Channel

7.3.4.5 Spain Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.5.1 By Product Type

7.3.4.5.2 By Diabetes Type

7.2.4.5.3 By Distribution Channel

7.3.4.6 Netherlands Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.6.1 By Product Type

7.3.4.6.2 By Diabetes Type

7.2.4.6.3 By Distribution Channel

7.3.4.7 Rest of Europe Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.7.1 By Product Type

7.3.4.7.2 By Diabetes Type

7.2.4.7.3 By Distribution Channel

7.4 Asia Pacific Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.1 By Product Type

7.4.2 By Diabetes Type

7.4.3 By Distribution Channel

7.4.4 By Country

7.4.4.1 China Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.1.1 By Product Type

7.4.4.1.2 By Diabetes Type

7.4.4.1.3 By Distribution Channel

7.4.4.2 Japan Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.2.1 By Product Type

7.4.4.2.2 By Diabetes Type

7.4.4.2.3 By Distribution Channel

7.4.4.3 India Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.3.1 By Product Type

7.4.4.3.2 By Diabetes Type

7.4.4.3.3 By Distribution Channel

7.4.4.4 South Korea Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.4.1 By Product Type

7.4.4.4.2 By Diabetes Type

7.4.4.4.3 By Distribution Channel

7.4.4.5 Singapore Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.5.1 By Product Type

7.4.4.5.2 By Diabetes Type

7.4.4.5.3 By Distribution Channel

7.4.4.6 Malaysia Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.6.1 By Product Type

7.4.4.6.2 By Diabetes Type

7.4.4.6.3 By Distribution Channel

7.4.4.7 Thailand Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.7.1 By Product Type

7.4.4.7.2 By Diabetes Type

7.4.4.7.3 By Distribution Channel

7.4.4.8 Indonesia Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.8.1 By Product Type

7.4.4.8.2 By Diabetes Type

7.4.4.8.3 By Distribution Channel

7.4.4.9 Vietnam Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.9.1 By Product Type

7.4.4.9.2 By Diabetes Type

7.4.4.9.3 By Distribution Channel

7.4.4.10 Taiwan Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.10.1 By Product Type

7.4.4.10.2 By Diabetes Type

7.4.4.10.3 By Distribution Channel

7.4.4.11 Rest of Asia Pacific Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.11.1 By Product Type

7.4.4.11.2 By Diabetes Type

7.4.4.11.3 By Distribution Channel

7.5 Middle East and Africa Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.1 By Product Type

7.5.2 By Diabetes Type

7.5.3 By Distribution Channel

7.5.4 By Country

7.5.4.1 Saudi Arabia Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.1.1 By Product Type

7.5.4.1.2 By Diabetes Type

7.5.4.1.3 By Distribution Channel

7.5.4.2 U.A.E. Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.2.1 By Product Type

7.5.4.2.2 By Diabetes Type

7.5.4.2.3 By Distribution Channel

7.5.4.3 Israel Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.3.1 By Product Type

7.5.4.3.2 By Diabetes Type

7.5.4.3.3 By Distribution Channel

7.5.4.4 South Africa Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.4.1 By Product Type

7.5.4.4.2 By Diabetes Type

7.5.4.4.3 By Distribution Channel

7.5.4.5 Rest of Middle East and Africa Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.5.1 By Product Type

7.5.4.5.2 By Diabetes Type

7.5.4.5.2 By Distribution Channel

7.6 Central & South America Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.6.1 By Product Type

7.6.2 By Diabetes Type

7.6.3 By Distribution Channel

7.6.4 By Country

7.6.4.1 Brazil Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.1.1 By Product Type

7.6.4.1.2 By Diabetes Type

7.6.4.1.3 By Distribution Channel

7.6.4.2 Argentina Eaporative Air Cooler Market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.2.1 By Product Type

7.6.4.2.2 By Diabetes Type

7.6.4.2.3 By Distribution Channel

7.6.4.3 Chile Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.3.1 By Product Type

7.6.4.3.2 By Diabetes Type

7.6.4.3.3 By Distribution Channel

7.6.4.4 Rest of Central & South America Fast-acting Human Insulin Market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.4.1 By Product Type

7.6.4.4.2 By Diabetes Type

7.6.4.4.3 By Distribution Channel

8 COMPETITIVE LANDCAPE

8.1 Company Market Share Analysis

8.2 Four Quadrant Positioning Matrix

8.2.1 Market Leaders

8.2.2 Market Visionaries

8.2.3 Market Challengers

8.2.4 Niche Market Players

8.3.4 Rest of the World

8.4 Company Profiles

8.4.1 Sanofi S.A.

8.4.1.1 Business Description & Financial Analysis

8.4.1.2 SWOT Analysis

8.4.1.3 Products & Services Offered

8.4.1.4 Strategic Alliances between Business Partners

8.4.2 Geropharm LLC

8.4.2.1 Business Description & Financial Analysis

8.4.2.2 SWOT Analysis

8.4.2.3 Products & Services Offered

8.4.2.4 Strategic Alliances between Business Partners

8.4.3 Gan & Lee Pharmaceuticals

8.4.3.1 Business Description & Financial Analysis

8.4.3.2 SWOT Analysis

8.4.3.3 Products & Services Offered

8.4.3.4 Strategic Alliances between Business Partners

8.4.4 Wockhadt Ltd.

8.4.4.1 Business Description & Financial Analysis

8.4.4.2 SWOT Analysis

8.4.4.3 Products & Services Offered

8.4.4.4 Strategic Alliances between Business Partners

8.4.5 Novo Nordisk A/S

8.4.5.1 Business Description & Financial Analysis

8.4.5.2 SWOT Analysis

8.4.5.3 Products & Services Offered

8.4.5.4 Strategic Alliances between Business Partners

8.4.6 ELI LILLY AND COMPANY

8.4.6.1 Business Description & Financial Analysis

8.4.6.2 SWOT Analysis

8.4.6.3 Products & Services Offered

8.4.6.4 Strategic Alliances between Business Partners

8.4.7 Mannkind Corporation

8.4.7.1 Business Description & Financial Analysis

8.4.7.2 SWOT Analysis

8.4.7.3 Products & Services Offered

8.4.8.4 Strategic Alliances between Business Partners

8.4.8 Biocon Limited

8.4.8.1 Business Description & Financial Analysis

8.4.8.2 SWOT Analysis

8.4.8.3 Products & Services Offered

8.4.8.4 Strategic Alliances between Business Partners

8.4.9 Sky Air Coolar

8.4.9.1 Business Description & Financial Analysis

8.4.9.2 SWOT Analysis

8.4.9.3 Products & Services Offered

8.4.9.4 Strategic Alliances between Business Partners

8.4.10 Julphar

8.4.10.1 Business Description & Financial Analysis

8.4.10.2 SWOT Analysis

8.4.10.3 Products & Services Offered

8.4.10.4 Strategic Alliances between Business Partners

8.4.11 Other Companies

8.4.11.1 Business Description & Financial Analysis

8.4.11.2 SWOT Analysis

8.4.11.3 Products & Services Offered

8.4.11.4 Strategic Alliances between Business Partners

9 RESEARCH METHODOLOGY

9.1 Market Introduction

9.1.1 Market Definition

9.1.2 Market Scope & Segmentation

9.2 Information Procurement

9.2.1 Secondary Research

9.2.1.1 Purchased Databases

9.2.1.2 GMEs Internal Data Repository

9.2.1.3 Secondary Resources & Third Party Perspectives

9.2.1.4 Company Information Sources

9.2.2 Primary Research

9.2.2.1 Various Types of Respondents for Primary Interviews

9.2.2.2 Number of Interviews Conducted throughout the Research Process

9.2.2.3 Primary Stakeholders

9.2.2.4 Discussion Guide for Primary Participants

9.2.3 Expert Panels

9.2.3.1 Expert Panels Across 30+ Industry

9.2.4 Paid Local Experts

9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region

9.3 Market Estimation

9.3.1 Top-Down Approach

9.3.1.1 Macro-Economic Indicators Considered

9.3.1.2 Micro-Economic Indicators Considered

9.3.2 Bottom Up Approach

9.3.2.1 Company Share Analysis Approach

9.3.2.2 Estimation of Potential Product Sales

9.4 Data Triangulation

9.4.1 Data Collection

9.4.2 Time Series, Cross Sectional & Panel Data Analysis

9.4.3 Cluster Analysis

9.5 Analysis and Output

9.5.1 Inhouse AI Based Real Time Analytics Tool

9.5.2 Output From Desk & Primary Research

9.6 Research Assumptions & Limitations

9.7.1 Research Assumptions

9.7.2 Research Limitations

LIST OF TABLES

1 Global Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Mllion)

2 Lispro Insulin Market, By Region, 2020-2028 (USD Mllion)

3 Aspart Insulin Market, By Region, 2020-2028 (USD Mllion)

4 Glulisine Insulin Market, By Region, 2020-2028 (USD Mllion)

5 Global Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Mllion)

6 Type 1 Diabetes Market, By Region, 2020-2028 (USD Mllion)

7 Type 2 Diabetes Market, By Region, 2020-2028 (USD Mllion)

8 Global Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Mllion)

9 Hospital Pharmacies Market, By Region, 2020-2028 (USD Mllion)

10 Drug Stores & Retail Pharmacies Market, By Region, 2020-2028 (USD Mllion)

11 Online Providers Market, By Region, 2020-2028 (USD Mllion)

12 Regional Analysis, 2020-2028 (USD Mllion)

13 North America Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

14 North America Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

15 North America Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

16 North America Fast-acting Human Insulin Market, By Country, 2020-2028 (USD Million)

17 U.S Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

18 U.S Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

19 U.S Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

20 Canada Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

21 Canada Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

22 Canada Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

23 Mexico Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

24 Mexico Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

25 Mexico Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

26 Europe Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

27 Europe Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

28 Europe Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

29 Germany Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

30 Germany Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

31 Germany Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

32 UK Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

33 UK Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

34 UK Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

35 France Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

36 France Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

37 France Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

38 Italy Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

39 Italy Fast-acting Human Insulin Market, By T End Use Type, 2020-2028 (USD Million)

40 Italy Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

41 Spain Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

42 Spain Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

43 Spain Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

44 Rest Of Europe Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

45 Rest Of Europe Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

46 Rest of Europe Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

47 Asia Pacific Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

48 Asia Pacific Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

49 Asia Pacific Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

50 Asia Pacific Fast-acting Human Insulin Market, By Country, 2020-2028 (USD Million)

51 China Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

52 China Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

53 China Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

54 India Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

55 India Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

56 India Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

57 Japan Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

58 Japan Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

59 Japan Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

60 South Korea Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

61 South Korea Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

62 South Korea Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

63 Middle East and Africa Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

64 Middle East and Africa Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

65 Middle East and Africa Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

66 Middle East and Africa Fast-acting Human Insulin Market, By Country, 2020-2028 (USD Million)

67 Saudi Arabia Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

68 Saudi Arabia Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

69 Saudi Arabia Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

70 UAE Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

71 UAE Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

72 UAE Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

73 Central & South America Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

74 Central & South America Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

75 Central & South America Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

76 Central & South America Fast-acting Human Insulin Market, By Country, 2020-2028 (USD Million)

77 Brazil Fast-acting Human Insulin Market, By Product Type, 2020-2028 (USD Million)

78 Brazil Fast-acting Human Insulin Market, By Diabetes Type, 2020-2028 (USD Million)

79 Brazil Fast-acting Human Insulin Market, By Distribution Channel, 2020-2028 (USD Million)

80 Sanofi S.A.: Products & Services Offering

81 Geropharm LLC: Products & Services Offering

82 Gan & Lee Pharmaceuticals: Products & Services Offering

83 Wockhadt Ltd.: Products & Services Offering

84 Novo Nordisk A/S: Products & Services Offering

85 ELI LILLY AND COMPANY: Products & Services Offering

86 Mannkind Corporation : Products & Services Offering

87 Biocon Limited: Products & Services Offering

88 ADOCIA SAS: Products & Services Offering

89 Julphar: Products & Services Offering

90 Other Companies: Products & Services Offering

LIST OF FIGURES

1 Global Fast-acting Human Insulin Market Overview

2 Global Fast-acting Human Insulin Market Value From 2020-2028 (USD Mllion)

3 Global Fast-acting Human Insulin Market Share, By Product Type (2022)

4 Global Fast-acting Human Insulin Market Share, By Diabetes Type (2022)

5 Global Fast-acting Human Insulin Market Share, By Distribution Channel (2022)

6 Global Fast-acting Human Insulin Market, By Region (Asia Pacific Market)

7 Technological Trends In Global Fast-acting Human Insulin Market

8 Four Quadrant Competitor Positioning Matrix

9 Impact Of Macro & Micro Indicators On The Market

10 Impact Of Key Drivers On The Global Fast-acting Human Insulin Market

11 Impact Of Challenges On The Global Fast-acting Human Insulin Market

12 Porter’s Five Forces Analysis

13 Global Fast-acting Human Insulin Market: By Product Type Scope Key Takeaways

14 Global Fast-acting Human Insulin Market, By Product Type Segment: Revenue Growth Analysis

15 Lispro Insulin Market, By Region, 2020-2028 (USD Mllion)

16 Aspart Insulin Market, By Region, 2020-2028 (USD Mllion)

17 Glulisine Insulin Market, By Region, 2020-2028 (USD Mllion)

18 Global Fast-acting Human Insulin Market: By Diabetes Type Scope Key Takeaways

19 Global Fast-acting Human Insulin Market, By Diabetes Type Segment: Revenue Growth Analysis

20 Type 1 Diabetes Market, By Region, 2020-2028 (USD Mllion)

21 Type 2 Diabetes Market, By Region, 2020-2028 (USD Mllion)

22 Global Fast-acting Human Insulin Market: By Distribution Channel Scope Key Takeaways

23 Global Fast-acting Human Insulin Market, By Distribution Channel Segment: Revenue Growth Analysis

24 Hospital Pharmacies Market, By Region, 2020-2028 (USD Mllion)

25 Drug Stores & Retail Pharmacies Market, By Region, 2020-2028 (USD Mllion)

26 Online Providers Market, By Region, 2020-2028 (USD Mllion)

27 Regional Segment: Revenue Growth Analysis

28 Global Fast-acting Human Insulin Market: Regional Analysis

29 North America Fast-acting Human Insulin Market Overview

30 North America Fast-acting Human Insulin Market, By Product Type

31 North America Fast-acting Human Insulin Market, By Diabetes Type

32 North America Fast-acting Human Insulin Market, By Distribution Channel

33 North America Fast-acting Human Insulin Market, By Country

34 U.S. Fast-acting Human Insulin Market, By Product Type

35 U.S. Fast-acting Human Insulin Market, By Diabetes Type

36 U.S. Fast-acting Human Insulin Market, By Distribution Channel

37 Canada Fast-acting Human Insulin Market, By Product Type

38 Canada Fast-acting Human Insulin Market, By Diabetes Type

39 Canada Fast-acting Human Insulin Market, By Distribution Channel

40 Mexico Fast-acting Human Insulin Market, By Product Type

41 Mexico Fast-acting Human Insulin Market, By Diabetes Type

42 Mexico Fast-acting Human Insulin Market, By Distribution Channel

43 Four Quadrant Positioning Matrix

44 Company Market Share Analysis

45 Sanofi S.A.: Company Snapshot

46 Sanofi S.A.: SWOT Analysis

47 Sanofi S.A.: Geographic Presence

48 Geropharm LLC: Company Snapshot

49 Geropharm LLC: SWOT Analysis

50 Geropharm LLC: Geographic Presence

51 Gan & Lee Pharmaceuticals: Company Snapshot

52 Gan & Lee Pharmaceuticals: SWOT Analysis

53 Gan & Lee Pharmaceuticals: Geographic Presence

54 Wockhadt Ltd.: Company Snapshot

55 Wockhadt Ltd.: Swot Analysis

56 Wockhadt Ltd.: Geographic Presence

57 Novo Nordisk A/S: Company Snapshot

58 Novo Nordisk A/S: SWOT Analysis

59 Novo Nordisk A/S: Geographic Presence

60 ELI LILLY AND COMPANY: Company Snapshot

61 ELI LILLY AND COMPANY: SWOT Analysis

62 ELI LILLY AND COMPANY: Geographic Presence

63 Mannkind Corporation : Company Snapshot

64 Mannkind Corporation : SWOT Analysis

65 Mannkind Corporation : Geographic Presence

66 Biocon Limited: Company Snapshot

67 Biocon Limited: SWOT Analysis

68 Biocon Limited: Geographic Presence

69 ADOCIA SAS.: Company Snapshot

70 ADOCIA SAS.: SWOT Analysis

71 ADOCIA SAS.: Geographic Presence

72 Julphar: Company Snapshot

73 Julphar: SWOT Analysis

74 Julphar: Geographic Presence

75 Other Companies: Company Snapshot

76 Other Companies: SWOT Analysis

77 Other Companies: Geographic Presence

The Global Fast-acting Human Insulin Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Fast-acting Human Insulin Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global fast-acting human insulin market?

The global fast-acting human insulin market is expected to grow at a CAGR of 4.5% from 2023 to 2028.

Who are the major vendors in the global fast-acting human insulin market?

The key players operating in the market are Sanofi S.A., Geropharm LLC, Gan & Lee Pharmaceuticals, Wockhardt Ltd., Novo Nordisk A/S, Eli Lilly And Company, Mannkind Corporation, Biocon Limited, ADOCIA SAS, and Julphar among others.

What are the opportunities prevailing in the global fast-acting human insulin market?

The global fast-acting human insulin market is expected to gain opportunities due to the rising prevalence of diabetic patients and growth in the healthcare infrastructure for diabetes. Additionally, there are opportunities related to research and development for different fast-acting human insulin formulations.

What are the major drivers for the global fast-acting human insulin market growth?

The main driving factors of the global market growth are rising prevalence of diabetic patients and growth in the healthcare infrastructure for diabetes.